217 related articles for article (PubMed ID: 29764445)
1. Current practices of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the treatment of peritoneal surface malignancies: an international survey of oncologic surgeons.
Yoo HJ; Hong JJ; Ko YB; Lee M; Kim Y; Han HY; Song YJ; Lim MC; Park SY
World J Surg Oncol; 2018 May; 16(1):92. PubMed ID: 29764445
[TBL] [Abstract][Full Text] [Related]
2. Current practice in cytoreductive surgery and HIPEC for metastatic peritoneal disease: Spanish multicentric survey.
Morales-Soriano R; Esteve-Pérez N; Segura-Sampedro JJ; Cascales-Campos P; Barrios P;
Eur J Surg Oncol; 2018 Feb; 44(2):228-236. PubMed ID: 29242018
[TBL] [Abstract][Full Text] [Related]
3. Current Delivery of Hyperthermic Intraperitoneal Chemotherapy with Cytoreductive Surgery (CS/HIPEC) and Perioperative Practices: An International Survey of High-Volume Surgeons.
Maciver AH; Al-Sukhni E; Esquivel J; Skitzki JJ; Kane JM; Francescutti VA
Ann Surg Oncol; 2017 Apr; 24(4):923-930. PubMed ID: 27900630
[TBL] [Abstract][Full Text] [Related]
4. Current practice of Latin American centers in the treatment of peritoneal diseases with cytoreductive surgery with HIPEC.
Latin American Registry of Peritoneal Diseases – LARPD participants
Eur J Surg Oncol; 2018 Nov; 44(11):1800-1804. PubMed ID: 30037640
[TBL] [Abstract][Full Text] [Related]
5. Cytoreduction with hyperthermic intraperitoneal chemotherapy: an appraisal of outcomes and cost at a newly established peritoneal malignancy program.
Hinkle NM; MacDonald J; Sharpe JP; Dickson P; Deneve J; Munene G
Am J Surg; 2016 Sep; 212(3):413-8. PubMed ID: 27086201
[TBL] [Abstract][Full Text] [Related]
6. The current practice of cytoreductive surgery and HIPEC for colorectal peritoneal metastases: Results of a worldwide web-based survey of the Peritoneal Surface Oncology Group International (PSOGI).
Bushati M; Rovers KP; Sommariva A; Sugarbaker PH; Morris DL; Yonemura Y; Quadros CA; Somashekhar SP; Ceelen W; Dubé P; Li Y; Verwaal VJ; Glehen O; Piso P; Spiliotis J; Teo MCC; González-Moreno S; Cashin PH; Lehmann K; Deraco M; Moran B; de Hingh IHJT
Eur J Surg Oncol; 2018 Dec; 44(12):1942-1948. PubMed ID: 30075978
[TBL] [Abstract][Full Text] [Related]
7. Treatment of intraoperatively detected peritoneal carcinomatosis of colorectal origin with cytoreductive surgery and intraperitoneal chemotherapy.
Canda AE; Arslan C; Terzi C; Sokmen S; Yavuzsen T; Ozkardesler S; Unlu M; Obuz F; Fuzun M
World J Surg Oncol; 2018 Mar; 16(1):70. PubMed ID: 29587771
[TBL] [Abstract][Full Text] [Related]
8. Extreme cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: Outcomes from a single tertiary center.
Berger Y; Aycart S; Mandeli JP; Heskel M; Sarpel U; Labow DM
Surg Oncol; 2015 Sep; 24(3):264-9. PubMed ID: 26143715
[TBL] [Abstract][Full Text] [Related]
9. Cytoreductive surgery and HIPEC in treatment of colorectal peritoneal carcinomatosis: experiment or standard care? A survey among oncologic surgeons and medical oncologists.
Braam HJ; Boerma D; Wiezer MJ; van Ramshorst B
Int J Clin Oncol; 2015 Oct; 20(5):928-34. PubMed ID: 25788217
[TBL] [Abstract][Full Text] [Related]
10. [Surgical Management of Peritoneal Surface Malignancy with Respect to Tumour Type, Tumour Stage and Individual Tumour Biology].
Beckert S; Struller F; Grischke EM; Glatzle J; Zieker D; Königsrainer A; Königsrainer I
Zentralbl Chir; 2016 Aug; 141(4):415-20. PubMed ID: 24241953
[TBL] [Abstract][Full Text] [Related]
11. Professional risks when carrying out cytoreductive surgery for peritoneal malignancy with hyperthermic intraperitoneal chemotherapy (HIPEC): A French multicentric survey.
Ferron G; Simon L; Guyon F; Glehen O; Goere D; Elias D; Pocard M; Gladieff L; Bereder JM; Brigand C; Classe JM; Guilloit JM; Quenet F; Abboud K; Arvieux C; Bibeau F; De Chaisemartin C; Delroeux D; Durand-Fontanier S; Goasguen N; Gouthi L; Heyd B; Kianmanesh R; Leblanc E; Loi V; Lorimier G; Marchal F; Mariani P; Mariette C; Meeus P; Msika S; Ortega-Deballon P; Paineau J; Pezet D; Piessen G; Pirro N; Pomel C; Porcheron J; Pourcher G; Rat P; Regimbeau JM; Sabbagh C; Thibaudeau E; Torrent JJ; Tougeron D; Tuech JJ; Zinzindohoue F; Lundberg P; Herin F; Villeneuve L;
Eur J Surg Oncol; 2015 Oct; 41(10):1361-7. PubMed ID: 26263848
[TBL] [Abstract][Full Text] [Related]
12. [Cytoreductive surgery and HIPEC for peritoneal malignancies in children].
Seitz G; Fuchs J; Königsrainer I; Warmann SW; Königsrainer A; Beckert S
Zentralbl Chir; 2014 Dec; 139(6):607-12. PubMed ID: 25531634
[TBL] [Abstract][Full Text] [Related]
13. Cirrhosis is not a contraindication to cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in highly selected patients.
Weiss A; Ward EP; Baumgartner JM; Lowy AM; Kelly KJ
World J Surg Oncol; 2018 Apr; 16(1):87. PubMed ID: 29699564
[TBL] [Abstract][Full Text] [Related]
14. Repeated cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with recurrent peritoneal carcinomatosis.
Vassos N; Förtsch T; Aladashvili A; Hohenberger W; Croner RS
World J Surg Oncol; 2016 Feb; 14(1):42. PubMed ID: 26912149
[TBL] [Abstract][Full Text] [Related]
15. Enterocutaneous fistula in patients with peritoneal malignancy following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: Incidence, management and outcomes.
Valle SJ; Alzahrani N; Alzahrani S; Traiki TB; Liauw W; Morris DL
Surg Oncol; 2016 Sep; 25(3):315-20. PubMed ID: 27566038
[TBL] [Abstract][Full Text] [Related]
16. Operating personnel safety during the administration of Hyperthermic Intraperitoneal Chemotherapy (HIPEC).
Kyriazanos I; Kalles V; Stefanopoulos A; Spiliotis J; Mohamed F
Surg Oncol; 2016 Sep; 25(3):308-14. PubMed ID: 27566037
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic Nodes of Patient Selection for Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Among Colorectal Cancer Patients: A Swiss National Multicenter Survey.
Steffen T; Putora PM; Hübner M; Gloor B; Lehmann K; Kettelhack C; Adamina M; Peterli R; Schmidt J; Ris F; Glatzer M
Clin Colorectal Cancer; 2019 Dec; 18(4):e335-e342. PubMed ID: 31371166
[TBL] [Abstract][Full Text] [Related]
18. Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy with lobaplatin and docetaxel improves survival for patients with peritoneal carcinomatosis from abdominal and pelvic malignancies.
Wu HT; Yang XJ; Huang CQ; Sun JH; Ji ZH; Peng KW; Zhang Q; Li Y
World J Surg Oncol; 2016 Sep; 14(1):246. PubMed ID: 27633880
[TBL] [Abstract][Full Text] [Related]
19. Hyperthermic intraperitoneal chemotherapy plus simultaneous versus staged cytoreductive surgery for gastric cancer with occult peritoneal metastasis.
Wu X; Li Z; Li Z; Jia Y; Shan F; Ji X; Bu Z; Zhang L; Wu A; Ji J
J Surg Oncol; 2015 Jun; 111(7):840-7. PubMed ID: 25864884
[TBL] [Abstract][Full Text] [Related]
20. Peritoneal metastases from small bowel cancer: Results of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in The Netherlands.
van Oudheusden TR; Lemmens VE; Braam HJ; van Ramshorst B; Meijerink J; te Velde EA; Mehta AM; Verwaal VJ; de Hingh IH
Surgery; 2015 Jun; 157(6):1023-7. PubMed ID: 25818658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
